Rationale and Design of the Prevention of Cardiac Dysfunction during an Adjuvant Breast Cancer Therapy (PRADA) Trial

Publisher： Karger

E-ISSN： 1421-9751|123|4|240-247

ISSN： 0008-6312

Source： Cardiology, Vol.123, Iss.4, 2012-11, pp. : 240-247

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endometrial Metastasis from Breast Cancer during Adjuvant Endocrine Therapy

By  

Case Reports in Oncology, Vol. 3, Iss. 2, 2010-04 ,pp. : 137-141

Karger

Access to resources Recommend Favorite

Bisphosphonates as adjuvant therapy for breast cancer

By Burkinshaw Roger   Coleman Robert  

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 115-126

Future Medicine

Access to resources Recommend Favorite

Prevention of sudden cardiac death: rationale and design of the Implantable Cardioverter Defibrillators in Dialysis patients (ICD2) Trial – a prospective pilot study

By de Bie Mihaly K.   Lekkerkerker Jaco C.   van Dam Bastiaan   Gaasbeek Andre   van Buren Marjolijn   Putter Hein   van Erven Lieselot   Bax Jeroen J.   Schalij Martin J.   Rabelink Ton J.   Jukema J. Wouter  

Current Medical Research and Opinion, Vol. 24, Iss. 8, 2008-08 ,pp. : 2151-2157

Informa Healthcare

Access to resources Recommend Favorite

Extended adjuvant endocrine therapy of early breast cancer

By Chowdhury Simon   Ellis Paul  

Current Medical Research and Opinion, Vol. 21, Iss. 12, 2005-12 ,pp. : 1985-1995

Informa Healthcare

Access to resources Recommend Favorite

Optimal adjuvant endocrine therapy for early breast cancer

By Stuart-Harris Robin   Davis Alison  

Women's Health, Vol. 6, Iss. 3, 2010-05 ,pp. : 383-398

Future Medicine

Access to resources Recommend Favorite